Clinical Ph II, now going to Clinical Phase III, it's HUGE 80% plus FAIL Clinical II Trials in Drug making. This is Phase II that will give the GREEN Light that the Drug is working the way it is supposed.
Clinical Phase II has many patients, 1000's and it is a Blind Study meaning that those who are on current drugs , most will continue while others will be given XRX.
This will determine if XRX is superior or doing a job just as good if not better than what is on market. INVESTIGATION and patient monitoring continues for several months.
My opinion, what XRX has, there is no Pharma who can come close to prove they are better than what XRX has achieved so far, only ONE Company out there but inferior to XRX.
I hope we SWEEP this one in Clinical trial III after NASDAQ,,,very soon.